Can biomarkers guide MS treatment? new trial aims to find out
NCT ID NCT03109288
First seen Jun 26, 2026 · Last updated Jul 29, 2026 · Updated 7 times
Summary
This study tests whether changes in spinal fluid biomarkers can predict which drug or drug combination works best for people with progressive multiple sclerosis (MS). Participants will take one or two of five drugs (cilostazol, leucovorin, pirfenidone, dantrolene, or pioglitazone) for up to 18 months. The goal is to slow disability progression by tailoring treatment to each person's unique disease activity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cilostazol, Leucovorin, Pirfenidone, Dantrolene, Pioglitazone
- What this could lead to
- If successful, this could lead to personalized combination therapies for progressive MS, slowing disability progression based on individual biomarkers.
- What could go wrong
- This is an early-phase trial (Phase 1/2) with only 250 participants, so results may not apply to all MS patients. The drugs may cause side effects or fail to show benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?